Drugs / BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED
BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 24 trials | ||||||
| Phase 2 | NCT05997264 | Dec 2023 → Aug 2025 overdue | anthrax infection | Biomedical Advanced Research and Development Authority | Active not recruiting | No outcome recorded |
| Phase 2 | NCT04067011 | Aug 2019 → Mar 2020 | anthrax infection | Emergent BioSolutions | Completed | No outcome recorded |
| Phase 2 | NCT03518125 | May 2018 → Jan 2019 | anthrax infection | Biomedical Advanced Research and Development Authority | Completed | No outcome recorded |
| Phase 2 | NCT01770743 | Jan 2013 → Feb 2014 | anthrax infection | Emergent BioSolutions | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03877926 | Mar 2019 → Aug 2020 | anthrax infection | Emergent BioSolutions | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04660201 Comparator | May 2022 → Nov 2023 | anthrax infection | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068494 ↗ |
| Known as | Anthrax Vaccine Adsorbed, Adjuvanted | “This double-blinded randomized Phase 3 study evaluated the immunogenicity and safety of CYFENDUS® vaccine (AV7909; Anthrax Vaccine Adsorbed, Adjuvanted) to support licensure...” PMID 41401704 ↗ Dec 2025 |
| Known as | AV7909 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04660201 ↗ |
| Known as | Bacillus anthracis strain v770-np1-r antigens | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068494 ↗ |
| Known as | CYFENDUS | “This double-blinded randomized Phase 3 study evaluated the immunogenicity and safety of CYFENDUS® vaccine (AV7909; Anthrax Vaccine Adsorbed, Adjuvanted) to support licensure...” PMID 41401704 ↗ Dec 2025 |
| Modality | Vaccine | “an anthrax vaccine” NCT01770743 ↗ |
| Route | Intramuscular | “Route of administration: Intramuscular” NCT01770743 ↗ |